BMAL1 deficiency in macrophages exacerbates sepsis-induced inflammatory response and organ damage by regulating

Xinjian Li1, Feng Qi2, Bin Yao1

  • 1Department of General Surgery, Yingtan People's Hospital Yingtan, Jiangxi, China.

Insights

The study reveals that BMAL1 (Brain and Muscle ARNT-Like 1) suppresses inflammation and organ damage in sepsis. Lower BMAL1 levels worsen sepsis, while boosting it offers therapeutic potential.

Area of Science:

  • Molecular Biology
  • Immunology
  • Chronobiology

Background:

  • Circadian rhythm gene BMAL1's role in sepsis is not fully understood.
  • Sepsis involves complex inflammatory responses and organ damage.

Purpose of the Study:

  • To investigate the molecular mechanisms of BMAL1 in sepsis.
  • To explore BMAL1's influence on inflammatory responses and organ injury.

Main Methods:

  • Established in vivo (mice) and in vitro (macrophages) sepsis models.
  • Analyzed BMAL1 expression levels.
  • Manipulated BMAL1 expression (overexpression and inhibition).
  • Investigated downstream effector PGC-1α.

Main Results:

  • BMAL1 expression was significantly downregulated in macrophages and Kupffer cells during sepsis.
  • BMAL1 overexpression suppressed inflammation and promoted M2 macrophage polarization.
  • BMAL1 inhibition exacerbated sepsis-induced inflammation and organ injury.
  • PGC-1α was identified as a key downstream mediator of BMAL1's anti-inflammatory effects.

Conclusions:

  • BMAL1 plays a protective role in sepsis by regulating inflammatory responses.
  • BMAL1, via PGC-1α, mitigates acute inflammation and organ damage in sepsis.
  • BMAL1 emerges as a potential therapeutic target for sepsis treatment.